Aperio Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Aperio Group’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,294	Closed	-$336K	–	2105
2016 Q1	$336K	Buy	6,294 +1,806	+40%	+$133K	﹤0.01%	1589
2015 Q4	$507K	Sell	4,488 -289	-6%	-$31.8K	﹤0.01%	1331
2015 Q3	$562K	Buy	4,777 +632	+15%	+$82.5K	0.01%	1233
2015 Q2	$321K	Buy	4,145 +408	+11%	+$26.8K	﹤0.01%	1585
2015 Q1	$216K	Buy	+3,737	New	+$159K	﹤0.01%	1787

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Aperio Group's ANAC Position: Q2 2016 in Review

Aperio Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 6,294 shares — an estimated $336K sold.

Aperio Group first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $562K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Aperio Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Aperio Group sold 6,294 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $336K.
Aperio Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Aperio Group's ANACOR PHARMACEUTICALS INC COM position peaked at $562K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.